FDA Approves Imetelstat for Rare Low-Risk Blood Cancer ...Middle East

Medscape - News
The approval for the first-in-class agent is "potentially practice changing" given the lack of treatment options for transfusion-dependent lower-risk MDS patients. Medscape Medical News

Hence then, the article about fda approves imetelstat for rare low risk blood cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Imetelstat for Rare Low-Risk Blood Cancer )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News